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It is estimated that over 1 billion people worldwide 
have tuberculosis (TB).[1] However, breast tuber­
culosis (BTB) is a rare condition. The incidence has 
been reported as <0.1% of all surgical breast lesions 
seen in developed countries and 3 ­ 4.5% of breast 
lesions in countries where BTB is endemic,[2,3] although even in 
this setting, carcinoma is far more commonly encountered.[4] While 
BTB is considered a manifestation of extrapulmonary tuberculosis 
(EPTB), it represents only about 0.1% of the disease burden of EPTB. 
However, there has been a resurgence of EPTB as a result of HIV, with 
estimated incidences as high as 50% in countries where HIV infection 
is endemic.[5]
The right and left breasts are equally affected by BTB, which 
may be bilateral in ~3% of cases.[6] Up to 70% of patients may have 
associated axillary lymphadenopathy, often with visible axillary 
swelling.[7] Constitutional symptoms are unusual in the absence of 
systemic and particularly pulmonary TB.[4]
No clinical or radiological features are absolutely diagnostic of 
BTB. The diagnosis is usually readily confirmed by biopsy with 
histological examination or fine­needle aspiration and staining 
for acid­fast bacilli (AFB), mycobacterial culture or polymerase 
chain reaction (PCR) testing. While the main differential diagnosis 
is carcinoma, other considerations are idiopathic granulomatous 
mastitis and fungal infections. Most patients respond to standard anti­
TB therapy (ATT).[8] It has been suggested that patients in endemic 
areas who have a breast mass with granulomatous inflammation on 
histological examination should receive ATT, even if culture results 
are negative for TB.[9] There have been reports that sinuses, fistulas 
and deformities may occasionally require primary localised excision 
or simple mastectomy, but this is not standard care.[4]
Objectives
To identify the various radiological patterns of BTB, and to assess 
available treatment options and response to treatment.
Methods
We identified 64 patients with a histological or cytological confirmed 
diagnosis of BTB. One patient with discharging axillary nodes and 
breast oedema was included even though cytological findings were 
not confirmatory; 65 patients were therefore included in the data 
analysis. Patients were diagnosed between 2000 and 2013. Data were 
collected from Addington (n=60 patients) and King Edward VIII 
hospitals (n=5), Durban, South Africa. The study was approved by 
the Bioethics Research Committee at the University of KwaZulu­
Natal, Durban (Reference No. BF213/13). A retrospective chart and 
radiology review focused on demographic, clinical, mammographic 
and ultrasound patterns and diagnostic and treatment methods.
Mammograms (mediolateral oblique (MLO) and craniocaudal 
views) were done using a standard Mecatronica analogue 
mammo graphic unit (± digital processing). Ultrasound images 
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were obtained on the various standard 
units using a 7.5 ­ 12.5 MHz linear 
probe. Mammographic patterns were 
classified as follows: asymmetrical density, 
asymmetrical density with axillary nodes, 
inflammation with axillary nodes, mass, 
mass with axillary nodes, nodes only, and 
normal. Ultrasound patterns were classified 
as abscess, abscess with axillary nodes, 
mass, mass with axillary nodes, oedema, 
oedema with nodes, thickening, nodes only, 
and normal.
Histological and microbiological diag­
nosis was done by obtaining core biopsy 
samples using a 14­gauge needle. Cytological 
diagnosis was done by FNA biopsy. Lesion 
localisation was either achieved by palpation 
or ultrasound guided.
Descriptive statistics using proportions 
were used to analyse results.
Results
Sixty­four records of patients with 
pathology­proven BTB and one with strong 
clinical but inconclusive cytological findings 
were identified during the period 2000 ­ 
2013. Accurate clinic attendance records 
were available for the years 2009 ­ 2013, and 
during this 5­year period a total of 11  092 
patients underwent breast investigations and 
30 were diagnosed with BTB (prevalence 
for the period 0.3%). Demographics and 
clinical presentation are described in Table 1. 
The age range was 23 ­ 69 years (mean 38.5 
years). Of the 65 patients, 26 presented with 
an inflammatory mass or disseminated form 
of BTB. Other associated clinical features are 
set out in Table 2. Of the 65 patients, only 
one was lactating. HIV status was known in 
47 patients, of whom 34 were HIV­positive. 
While 47 patients had a history of previous 
pulmonary TB, only 15 had radiological 
evidence of either previous or concurrent 
pulmonary TB.
Radiological features on mammograms 
and ultrasound scans are summarised in 
Fig. 1 (a and b, respectively). Of the 33 
patients who had mammograms, 16 demon­
strated ipsilateral or bilateral axillary 
lymphadenopathy. A density pattern was 
seen in 13 cases. Ultrasound scans were done 
in 41 patients. The commonest pattern was 
that of an abscess (16 cases, 39.0%).
Sensitivity for fine­needle aspiration 
cytology (FNAC) was 28% as opposed to 
94% for histology. AFB were seen in 10.3% 
of the FNAC specimens and 29.7% of the 
histology specimens. Of the 65 patients, 
59 received medical treatment, 3 received 
surgical intervention, and 3 were lost to 
follow­up after diagnosis. Of those who 
were treated, 72.7% obtained full resolution, 
25.0% did not complete treatment, and 2.3% 
died (n=1).
Discussion
Clinical and radiological findings
Inflammatory/disseminated
This pattern was the most common clinical 
presentation of BTB. However, among patients 
who had mammograms, this pattern was 
seen in 21.2% (Fig. 2, a). The mammogram 
typically demonstrated nonspecific diffuse 
stromal thickening. We noted that all cases 
with an inflammatory/disseminated form also 






Age at presentation (years)
Range 23 ­ 69





Axillary nodes, n (%)
Yes 21 (33.9)
No 41 (66.1)
Clinical presentation, n (%)
Abscess 2 (3.1)
Adenitis + oedema 16 (24.6)
Mass (nodular) form 17 (26.2)
 Inflammatory mass 
(disseminated)
26 (40.0)
Occult mass 1 (1.5)
Unknown 3 (4.6)
SD = standard deviation.
Table 2. Associated clinical features
Characteristics n (%)
History of pulmonary TB 
(N=47)
CXR normal 32 (49.2)








Refused testing 1 (1.5)















































































































Fig. 1. (a) Of 33 patients who had mammograms, 16 demonstrated ipsilateral or bilateral axillary lymphadenopathy. An asymmetrical density pattern was 
seen in 13 cases. (b) Ultrasound scans were performed in 41 patients. The commonest pattern was an abscess variety in (16 cases, 39%).
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had nodes. This supports the hypothesis that this form may be due to 
either reactive oedema or retrograde spread from the axillary lymph 
nodes.[10] To date, no study has specifically determined whether AFB 
are present in the oedematous or diffusely inflamed breast. Because of 
the appearances, it has been suggested that this in fact represents the 
clinical spectrum from inflammatory mass/disseminated to oedema. The 
major differential diagnosis of this form is inflammatory breast cancer. 
However, the combination of an inflammatory breast lesion and sinuses 
or fistulas favours BTB rather than cancer.[3] On the ultrasound scan, some 
disseminated forms appeared as diffuse trabecular thickening and oedema 
(Fig. 2, c), whereas others demonstrated a diffuse inflammatory mass.
Oedema with adenitis
The clinical presentation of oedema was noted in 24.6% of cases, 
and an ultrasound pattern of oedema was seen in 26.9% (n=11). 
In contrast to the disseminated/inflammatory form, where all had 
associated axillary lymph nodes, seven patients in this group (17.1%) 
did not have associated lymphadenopathy. This pattern can be found 
in other forms of mastitis.
Abscess variety
Even though clinical evaluation classified an abscess variety of BTB 
in only 3.1%, this was the most common pattern on ultrasound, 
seen in 39.0% (n=18), with or without adenitis. Ultrasound scans 
demonstrated complex solid­cystic heterogeneous hypoechoic 
masses and fluid collections. In our study, asymmetrical density was 
the commonest mammographic pattern (39.4%, n=13) associated 
with this classification. Three patients only had ultrasound diagnosis. 
The differential diagnosis was a pyogenic abscess, and some of 
our patients had in fact received treatment with antibiotics; it was 
only after lack of response to this that the diagnosis of tubercular 
abscess was considered. It is therefore important to obtain samples 
specifically for TB analysis in all cases of non­lactational breast 
abscess, even if there is no history of TB elsewhere.
Nodular (focal mass)
Clinically this form of BTB presented as a focal mass. On the 
mammograms the focal mass opacities had variable outlines, some 
having smooth margins while others were irregular. Some were 
single mass lesions, and others were multiple (Fig. 3). This was 
the third most common mammographic pattern, seen in 18.2% of 
patients. On ultrasound this form appeared as a hypoechoic solid 
or heterogeneous mass with a variable outline ranging from well­
defined round to irregular. Lesion size based on ultrasound ranged 
from 0.9 cm to 6.1 cm. The differential diagnosis of this form can 
range from benign fibroadenoma to breast cancer, depending on the 
lesion character on imaging. We did not find microcalcification to be 
a feature in our study.
Tuberculous lymphadenitis
Although isolated lymphadenitis was not reported on clinical 
presentation, it was seen in 12.1% of mammograms (n=4) and 2.4% 
of ultrasound scans (n=1). Nodes were intramammary, axillary, or 
both. Clinically, large nodes can extend to the skin surface to form 
discharging sinuses (Fig. 4, a). The intramammary nodes appeared 
as well­defined round, dense masses on the mammogram. These can 
be confused with a breast mass when they are solitary. Radiological 
differentiation of tuberculous axillary nodes from metastatic nodes 
a b
c
Fig. 2. Inflammatory/disseminated BTB, images taken from various 
patients. (a) mammogram, MLO views. The right breast is enlarged. Diffuse 
stromal thickening and skin oedema is evident. (b) Photograph of the left 
breast, showing inflammation of the skin. (c) Ultrasound images showing 
diffuse trabecular thickening with oedema as hypoechoic bands in between 
hyperechoic fibrofatty tissue.
a b
Fig. 3. Nodular form of BTB. Mammogram, MLO views. (a) At presen-
tation – multiple rounded mass opacities in the right breast, and enlarged 
dense right axillary nodes. (b) After 4 months of treatment with ATT, one 
small round mass opacity remains in the upper part.
Fig. 4. Tuberculous lymphadenitis. (a) Left axilla, enlarged nodes discharging 
onto skin sinuses. (b) Ultrasound Doppler scan showing hilum vessel and 
thick cortex. (c) Ultrasound scan showing node with thick 7 mm cortex 
(callipers). (d) Breast MRI T1 post-contrast axial image. Right axillary 
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remains difficult. In our series, ultrasound scanning of axillary nodes 
demonstrated oval, hypoechoic solid masses with thick cortices and 
loss of normal fatty hilum (Fig. 4, b and c). This appearance cannot 
be differentiated from that of a malignant or metastatic lymph node. 
Post­contrast magnetic resonance imaging (MRI) showed peripheral 
enhancement with a central low signal (Fig. 4, d). Another author 
described nodes as having peripheral enhancement with central 
low attenuation (PRECLO) on positive emission tomography with 
fluorodeoxyglucose integrated with computed tomography (18F­FDG 
PET/CT).[11]
Pathological findings
We found FNAC to be only 28% sensitive, whereas the sensitivity of 
histopathology was 94%. Necrotising granulomatous inflammation 
was seen in histological specimens. In support of the literature, 
the yield of AFB in our study was low, being positive in 10.3% 
of cytology and 29.6% of histology specimens. In one case, AFB 
were detected histologically by PCR testing. Harris et al.[12] 
reported a 2% rate of positive Ziehl­Neelsen smears for AFB 
from tuberculous breast abscess fluid. Furthermore, an AFB­
positive smear is not always adequate for a definitive diagnosis 
of Mycobacterium tuberculosis, as it should be differentiated from 
other Mycobacterium species.
Treatment
Of the 65 patients, 59 received medical treatment comprising 9 
months of standard ATT, 3 received both medical and surgical 
intervention involving abscess drainage, and 3 were lost to follow­
up and were never treated following diagnosis. Of those who were 
treated, 72.7% obtained full clinical resolution, 25.0% did not 
complete treatment, and one patient died. Response to treatment 
was assessed by clinical examination and repeated radiological 
investigations (ultrasound, mammography or both). Although there 
are no documented criteria for radiological response, drug resistance 
may be suspected when lesions fail to reduce in size or change their 
appearance on ultrasound or mammography. Ultrasound is especially 
useful in monitoring the abscess form of BTB, to detect residual fluid 
collections. In single studies, both MRI[13] and 18F­FDG PET/CT[11] 
have shown promise as tools for monitoring response.
Risk factors
Our data demonstrate the varied spectrum of BTB presentation, 
both clinical and radiological, as well as good outcome with medical 
treatment. Furthermore, the study illustrates some association of 
BTB with HIV. Although most patients with BTB are females, male 
patients are occasionally affected. Our study supports this, with 
only one of 65 patients (1.5%) being male. The mean age of the 
patients in our study was 38.5 years, with a range of 23 ­ 69 years, 
demonstrating that BTB is not limited to females of reproductive 
age, as has been reported in the literature.[14] Several risk factors for 
BTB have been described, including lactation, multiparity and HIV/
AIDS.[12] We found only one patient (1.5%) to be lactating. HIV 
status was known in 47 of our patients, of whom 72.3% (n=34) were 
HIV­positive. Although HIV infection has been associated with an 
increased incidence of EPTB, BTB still remains rare. BTB has been 
classified as primary or secondary. Whereas most studies report that 
the primary form of BTB is rare,[9] we found the opposite. A history of 
pulmonary TB was obtained from 47 patients, of whom 68.1% (n=32) 
had a normal chest radiograph and no evidence of pulmonary or 
concurrent TB or of TB elsewhere in the body. This finding suggests 
that half of our cohort had the primary form of BTB.
Study limitations
Limitations due to the retrospective nature of the study include 
incomplete data on follow­up after treatment completion, even 
though patients were scheduled for further visits.
Conclusions
Our findings demonstrate the varied clinical and radiological 
presentations of BTB. Early diagnosis can lead to full response 
following treatment with standard ATT, resulting in avoidance of 
more invasive surgical treatment which can potentially cause breast 
disfigurement. Clinicians need to be aware of these patterns and to 
have a high index of suspicion in order to prevent misdiagnosis and 
inappropriate management.
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